Related references
Note: Only part of the references are listed.Critical Role for Hypothalamic mTOR Activity in Energy Balance
Hiroyuki Mori et al.
CELL METABOLISM (2009)
Glycogen Synthase Kinase-3 and Mammalian Target of Rapamycin Pathways Contribute to DNA Synthesis, Cell Cycle Progression, and Proliferation in Human Islets
Hui Liu et al.
DIABETES (2009)
Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic β-Cells Leads to Increased β-Cell Mass and Prevention of Hyperglycemia
Suirin Hamada et al.
DIABETES (2009)
mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability
Norman Balcazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor γ Response Element in the Mouse pdx-1 Promoter
Dhananjay Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biphasic response of pancreatic β-cell mass to ablation of tuberous sclerosis complex 2 in mice
Yutaka Shigeyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Regulation of TORC1 by Rag GTPases in nutrient response
Eunjung Kim et al.
NATURE CELL BIOLOGY (2008)
Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner
Latif Rachdi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
Rapamycin impairs β-cell proliferation in vivo
E. Zahr et al.
TRANSPLANTATION PROCEEDINGS (2008)
The proline-rich akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1
Noriko Oshiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
Lifu Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells
C. T. Bussiere et al.
DIABETOLOGIA (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity
Q Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass
N Hashimoto et al.
NATURE GENETICS (2006)
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
SL Cai et al.
JOURNAL OF CELL BIOLOGY (2006)
Selective deletion of Pten in pancreatic β cells leads to increased islet mass and resistance to STZ-induced diabetes
BL Stiles et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels -: Effects on cell cycle progression in rodent islets
G Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo
Kinh-Tung T. Nguyen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
L Meikle et al.
HUMAN MOLECULAR GENETICS (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells
M Murakami et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures
EJ Uhlmann et al.
ANNALS OF NEUROLOGY (2002)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
XS Gao et al.
NATURE CELL BIOLOGY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
DJ Kwiatkowski et al.
HUMAN MOLECULAR GENETICS (2002)
Intracellular signalling - Key enzyme in leptin-induced anorexia
KD Niswender et al.
NATURE (2001)
A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice
T Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
